Dr. Cesar A. Moran, MD

Dr. Moran practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Moran's NPI, 1376639393, was assigned on October 5, 2006. Dr. Moran graduated from Universidad de San Carlos FOMS in 1981. Dr. Moran's Texas license number on file is L4069.

Dr. Moran's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Moran's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moran practices. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Moran's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Moran is board certified in anatomic pathology by the American Board of Pathology. Dmand AI has Dr. Moran's licenses on file in 2 states: Texas and Alabama.

CMS data shows 2,135 Medicare services from Dr. Moran across 10 procedure codes in 2024, for 736 Medicare patients. Medicare paid $73,589 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 736 Medicare patients who saw Dr. Moran in 2024. The largest group is 65 to 74, with 400 patients. 75% of them have cancer, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moran's median patient age at 67, with 54% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Moran for performance year 2024, reported as part of a group. Dr. Moran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 279 papers to Dr. Moran, published from 2007 to 2025. 2020 was the busiest year, with 13. The most frequent topics are Immunohistochemistry, Lung Neoplasms and Thymus Neoplasms. Dr. Moran has published most often in Am J Surg Pathol. Dr. Moran's most frequent co-authors are Neda Kalhor, MD, Annikka Weissferdt, MD and Stephen G. Swisher, MD.

CMS Open Payments shows 59 general payments to Dr. Moran from 8 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 61% of the total. Merck Sharp & Dohme Corporation paid the most, $25,888. It also lists 1 research payment totaling $6,150 in 2017.

Dmand AI lists 4 awards for Dr. Moran, most recently America's Top Doctors in 2014.

Dr. Moran graduated from Universidad de San Carlos FOMS in 1981.

Dr. Moran is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.